Clinical features and prognosis of spontaneous bacterial peritonitis in Korean patients with liver cirrhosis: A multicenter retrospective study

Gut and Liver

Volumn 3, Issue 3, 2009, Pages 197-204

  Heo, Jeong ^a   Yeon, Seok Seo ^b   Hyung, Joon Yim ^b   Hahn, Taeho ^c   Sang, Hoon Park ^c   Sang, Hoon Ahn ^d   Jun, Yong Park ^d   Ji, Young Park ^e   Moon, Young Kim ^f   Sung, Keun Park ^g   Cho, Mong ^a   Soon, Ho Um ^b   Kwang, Hyub Han ^d   Hong, Soo Kim ^e   Soon, Koo Baik ^f   Byung, Ik Kim ^g   Se, Hyun Cho ^h  

^a Pusan National University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Soonchunhyang University College of Medicine   (South Korea)

^f Yonsei University Wonju College of Medicine   (South Korea)

^g Sungkyunkwan University   (South Korea)

^h The Catholic University of Korea   (South Korea)

Author keywords

Liver cirrhosis; Peritonitis; Prognosis; Resistance

Indexed keywords

AMPICILLIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; TEICOPLANIN;

ADULT; ARTICLE; BACTERIAL PERITONITIS; CANDIDA ALBICANS; CLINICAL FEATURE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SCORING SYSTEM; SOUTH KOREA; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 70349319567     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2009.3.3.197     Document Type: Article

References (46)

1. Runyon BA. Spontaneous bacterial peritonitis: an explosion of information. Hepatology 1988;8:171-175. (Pubitemid 18092078)
2. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998;27:669-674.
3. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002;35: 140-148. (Pubitemid 34032554)
4. Pinzello G, Simonetti RG, Craxi A, Di Piazza S, Spano C, Pagliaro L. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 1983;3:545-549.
5. Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001;34:32-37. (Pubitemid 32102566)
6. Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 1999;473:11-30.
7. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005;17:27-31. (Pubitemid 40128922)
8. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005;41:422-433.
9. Runyon BA. Early events in spontaneous bacterial peritonitis. Gut 2004;53:782-784. (Pubitemid 38662125)
10. De Fernandez MA, Clark A, Triger DR. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases. Clin Exp Immunol 1987; 67:655-661. (Pubitemid 17031809)
11. Fiuza C, Salcedo M, Clemente G, Tellado JM. Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease. Clin Diagn Lab Immunol 2002;9:433-439. (Pubitemid 34226043)
12. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986;91:1343-1346.
13. Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988;8:27-31. (Pubitemid 18092054)
14. Guarner C, Sola R, Soriano G, et al. Risk of a first community- acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 1999;117:414-419. (Pubitemid 29352951)
15. Kerr DN, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis. Gut 1963;4:394-398.
16. Conn HO. Spontaneous peritonitis and bacteremia in Laennec's cirrhosis caused by enteric organisms: a relatively common but rarely recognized syndrome. Ann Intern Med 1964;60:568-580.
17. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985;5:457-462. (Pubitemid 15065954)
18. Toledo C, Salmeron JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993;17:251-257. (Pubitemid 23046697)
19. Llovet JM, Planas R, Morillas R, et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993;88:388-392. (Pubitemid 23085848)
20. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994;20:1495-1501. (Pubitemid 24359062)
21. Rimola A, Salmeron JM, Clemente G, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995;21:674-679.
22. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-409. (Pubitemid 29362513)
23. Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990;12:716-724. (Pubitemid 20349256)
24. Rolachon A, Cordier L, Bacq Y, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 1995; 22:1171-1174.
25. Terg R, Llano K, Cobas SM, et al. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages. J Hepatol 1998; 29:437-442. (Pubitemid 28396661)
26. Singh N, Gayowski T, Yu VL, Wagener MM. Trimethoprim- sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 1995;122:595-598.
27. Dupeyron C, Mangeney N, Sedrati L, Campillo B, Fouet P, Leluan G. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 1994;38:340-344. (Pubitemid 24054258)
28. Yamaguchi K, Mathai D, Biedenbach DJ, Lewis MT, Gales AC, Jones RN. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1999;34:123-134.
29. Jones RN, Low DE, Pfaller MA. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic- resistant gram-positive bacteria: the role of streptogramins and other newer compounds. Diagn Microbiol Infect Dis 1999;33:101-112.
30. Goossens H. European status of resistance in nosocomial infections. Chemotherapy 2005;51:177-181. (Pubitemid 41404695)
31. Park YH, Lee HC, Song HG, et al. Recent increase in antibiotic- resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J Gastroenterol Hepatol 2003;18:927-933.
32. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997;17:203-217.
33. Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990;98:127-133. (Pubitemid 20017793)
34. Aparicio JR, Such J, Pascual S, et al. Development of quinolone- resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 1999;31:277-283. (Pubitemid 29349754)
35. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988;95: 1351-1355.
36. National Commettee for Clinical Laboratory Standards. Performance standard for antimicrobial disk susceptibility test: approved standard M2-A6. Vallanova: National Committee for Clinical Laboratory Standars, 1997.
37. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470. (Pubitemid 32119037)
38. Ricart E, Soriano G, Novella MT, et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 2000;32:596-602. (Pubitemid 30180379)
39. Correia JP, Conn HO. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am 1975; 59:963-981.
40. Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984;4:1209-1211. (Pubitemid 15192275)
41. Cho JH, Park KH, Kim SH, et al. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis. Scand J Infect Dis 2007;39:697-702. (Pubitemid 47180470)
42. Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou-Kastellanou C, Archimandritis AJ. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int 2005;25:57-61. (Pubitemid 40298245)
43. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003;37:897-901. (Pubitemid 36397402)
44. Grange JD, Roulot D, Pelletier G, et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol 1998;29:430-436. (Pubitemid 28396660)
45. Novella M, Sola R, Soriano G, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997;25:532-536. (Pubitemid 27106428)
46. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004;39:841-856. (Pubitemid 38337667)